缩写名/全名 |
ONCOTARGETS THER
OncoTargets and Therapy |
||||||||||||||||||||
ISSN号 | 1178-6930 | ||||||||||||||||||||
研究方向 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY-ONCOLOGY | ||||||||||||||||||||
影响因子 | 2015:2.272, 2016:2.612, 2017:2.656, 2018:3.046, 2019:3.337, | ||||||||||||||||||||
出版国家 | ENGLAND | ||||||||||||||||||||
出版周期 | |||||||||||||||||||||
年文章数 | 1051 | ||||||||||||||||||||
出版年份 | 2008 | ||||||||||||||||||||
是否OA | Yes | ||||||||||||||||||||
审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||||||
录用比例 | 较易 | ||||||||||||||||||||
投稿链接 | https://www.dovepress.com/submit_step_1.php | ||||||||||||||||||||
投稿官网 | https://www.dovepress.com/oncotargets-and-therapy-journal | ||||||||||||||||||||
h-index | 44 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1178-6930%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Ribonucleotide reductase subunit M2 as a novel target for clear-cell renal cell carcinoma. Author: Zou Y1, Zhou J1, Xu B1, Li W1, Wang Z1. Journal: Onco Targets Ther. 2019 Apr 30;12:3267-3275. doi: 10.2147/OTT.S196347. eCollection 2019. PubMed DOI |
2. | MEX3C regulates lipid metabolism to promote bladder tumorigenesis through JNK pathway. Author: Chao H1, Deng L2, Xu F3, Yu Z2, Xu X2, Huang J2, Zeng T4. Journal: Onco Targets Ther. 2019 May 1;12:3285-3294. doi: 10.2147/OTT.S199667. eCollection 2019. PubMed DOI |
3. | Increased MCL-1 expression predicts poor prognosis and disease recurrence in acute myeloid leukemia. Author: Li XX1,2, Zhou JD1,3,4, Wen XM3,5, Zhang TJ1,3,4, Wu DH6, Deng ZQ3,5, Zhang ZH1,3,4, Lian XY1,3,4, He PF1,3,4, Yao XY7, Lin J3,5, Qian J1,3,4. Journal: Onco Targets Ther. 2019 May 1;12:3295-3304. doi: 10.2147/OTT.S194549. eCollection 2019. PubMed DOI |
4. | High feasibility of cytological specimens for detection of ROS1 fusion by reverse transcriptase PCR in Chinese patients with advanced non-small-cell lung cancer. Author: Zhang L1,2, Wang Y1, Zhao C3, Shi J1, Zhao S1, Liu X1, Jia Y1, Zhu T4, Jiang T1, Li X3, Zhou C1. Journal: Onco Targets Ther. 2019 May 1;12:3305-3311. doi: 10.2147/OTT.S198827. eCollection 2019. PubMed DOI |
5. | Altered circulating levels of adipokine omentin-1 in patients with prostate cancer. Author: Zhou L1, He W2, Wang W1, Zhou D3. Journal: Onco Targets Ther. 2019 May 1;12:3313-3319. doi: 10.2147/OTT.S197507. eCollection 2019. PubMed DOI |
6. | Poor prognosis of pulmonary sarcomatoid carcinoma with KRAS mutation and ALK fusion. Author: Chen F1, Gu Q1, Hu C1, Cai X1, Lei S1. Journal: Onco Targets Ther. 2019 May 1;12:3321-3325. doi: 10.2147/OTT.S196751. eCollection 2019. PubMed DOI |
7. | Nicotine promotes cervical metastasis of oral cancer by regulating peroxiredoxin 1 and epithelial-mesenchymal transition in mice. Author: Wang M1, Niu W2, Qi M1, Chen H1, Zhang M1, Wang C1, Ge L1, Yang J1, Miao C1, Shi N3, Chen T3, Tang X1. Journal: Onco Targets Ther. 2019 May 1;12:3327-3338. doi: 10.2147/OTT.S194129. eCollection 2019. PubMed DOI |
8. | Fatty acid synthase enhances colorectal cancer cell proliferation and metastasis via regulating AMPK/mTOR pathway. Author: Lu T1, Sun L2, Wang Z1, Zhang Y1, He Z1, Xu C1. Journal: Onco Targets Ther. 2019 May 2;12:3339-3347. doi: 10.2147/OTT.S199369. eCollection 2019. PubMed DOI |
9. | LncRNA SNHG6 promotes the migration, invasion, and epithelial-mesenchymal transition of colorectal cancer cells by miR-26a/EZH2 axis. Author: Zhang M1, Duan W1, Sun W1. Journal: Onco Targets Ther. 2019 May 2;12:3349-3360. doi: 10.2147/OTT.S197433. eCollection 2019. PubMed DOI |
10. | CircHIPK3 overexpression accelerates the proliferation and invasion of prostate cancer cells through regulating miRNA-338-3p. Author: Cai C1, Zhi Y1, Wang K1, Zhang P1, Ji Z1, Xie C1, Sun F1. Journal: Onco Targets Ther. 2019 May 2;12:3363-3372. doi: 10.2147/OTT.S196931. eCollection 2019. PubMed DOI |
|
|